79669-87-7 Usage
Molecular Weight
258.33 g/mol
Functional Groups
Oxo (C=O) and Carboxylic Acid (COOH)
Structural Features
Complex structure with dibenzobicyclo and oxepine rings
Potential Applications
Pharmaceutical and chemical industries
Reactivity
Depends on further research and exploration in organic chemistry and chemical synthesis
Solubility
Not specified, but likely soluble in organic solvents due to its nonpolar nature
Stability
May be sensitive to heat, light, and moisture; further research needed to determine stability under various conditions
Toxicity
Not specified, but should be handled with care due to its complex structure and potential reactivity
Synthesis
The synthesis of this compound would involve multiple steps, including the formation of the dibenzobicyclo and oxepine rings, followed by the introduction of the oxo and carboxylic acid functional groups, and finally, the formation of the methyl ester
Purity
The purity of the compound would depend on the synthesis method and purification techniques employed
Safety Precautions
Use appropriate personal protective equipment (PPE) such as gloves, goggles, and lab coats when handling this compound, and follow proper disposal procedures for any waste generated during synthesis or use.
Check Digit Verification of cas no
The CAS Registry Mumber 79669-87-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,6,6 and 9 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 79669-87:
(7*7)+(6*9)+(5*6)+(4*6)+(3*9)+(2*8)+(1*7)=207
207 % 10 = 7
So 79669-87-7 is a valid CAS Registry Number.
79669-87-7Relevant articles and documents
Improved synthesis of thromboxane A2 receptor antagonists with a dibenzoxepin ring system
Sugaya,Kato,Sakaguchi,Tomioka
, p. 1257 - 1262 (2007/10/02)
Two derivatives of sodium (E)-11-[2-(1-benzimidazolyl)ethylidene]11-oxo-6,11-dihydrodibenz[b,e]o xepin-2-carboxylate, novel nonprostanoid thromboxane A2 (TXA2) receptor antagonists, were synthesized from methyl 11-oxo-6,11-dihydrodibenz[b,e]oxepin-2-carboxylate. The carbonyl group at C11 was converted into a formylmethylene, then into a 1-azadiene moiety by reaction with a 2-aminoformanilide derivative. Stereo- and regioselective elaboration of the unsymmetrical imidazoles was achieved through a sequence of the transformation of E,Z-1-azadiene intermediates to E isomers under acidic conditions followed by cyclization to imidazoles.
TRICYCLIC COMPOUNDS
-
, (2008/06/13)
Novel tricyclic compound represented by formula STR1 possess a TXA. sub.2 biosynthesis inhibiting activity and/or a TXA 2 receptor antagonizing activity, and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.
Dibenz[b,e]oxepin compounds
-
, (2008/06/13)
Novel dibenz[b,e]oxepin derivatives are employed in the treatment and control of allergic conditions such as allergic asthma.
